Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Kidney Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Fulvestrant 63Letrozole 53Paclitaxel 50Trastuzumab 42pembrolizumab 40ribociclib 38Specimen Handling 37palbociclib 36Capecitabine 35Carboplatin 33Anastrozole 33Tamoxifen 32exemestane 29pertuzumab 28abemaciclib 28Magnetic Resonance Spectroscopy 26Cyclophosphamide 26trastuzumab deruxtecan 25Surveys and Questionnaires 22Biopsy 19olaparib 18Standard of Care 18Radiotherapy 18Docetaxel 16Blood Specimen Collection 16elacestrant 14Taxes 14Mastectomy, Segmental 14eribulin 13Methods 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms × Biopsy, Large-Core Needle × 90 days × Clear all
NCT06127979 2026-06-02

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
42 enrolled
Breast

Breast Neoplasms

NCT03524430 2026-05-28

BREVITY

Rna Diagnostics Inc.

Phase NA Active not recruiting
801 enrolled
Breast

Breast Neoplasms

NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡